Cosmo Pharmaceuticals Logo

Cosmo Pharmaceuticals

🇮🇪
COPN
NL0011832936

Cosmo Pharmaceuticals is a specialty pharmaceutical company based in Ireland, focused on innovative therapies for gastroenterology and dermatology. The company develops and licenses advanced medicines and medical devices to improve patient care and address unmet needs in these therapeutic areas.

Next Quarterly Earnings

Thursday, July 23, 2026
CW 30
Pre-Market
In 11 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Currently in quiet period until July 23, 2026

Stock Price

Frequently asked questions

When will Cosmo Pharmaceuticals report its next quarterly earnings?

Cosmo Pharmaceuticals is scheduled to report its next quarterly earnings on 07/23/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Cosmo Pharmaceuticals last report quarterly earnings?

Cosmo Pharmaceuticals last reported quarterly earnings on 3/9/2026 (Q1 2026). Earnings per share (EPS) came in at -0.09 CHF.

How do I add the Cosmo Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:CHF 0.00
Actual:
Q1 2026
Estimate:
Actual:-CHF 0.09

Company Information

Name
Cosmo Pharmaceuticals
Ticker Symbol
COPN
ISIN
NL0011832936
Country
🇮🇪
Ireland
Sector
Healthcare